Moreover, a study by Clatworthy et al. has indicated that the monocyte-derived macrophages are increased in the peripheral blood of patients with the SLE-associated FcγRIIB-232T genotype [12], which could lead to the identification of opportunities for using this receptor as a therapeutic target. The gene discussed is FCGR2B; the disease is systemic lupus erythematosus.